We are live on
!
Find out more
TP
Truvvo Partners Portfolio holdings
AUM
$5.22M
1-Year Est. Return
13.74%
This Fund
S&P 500
This Quarter
Est. Return
+4.46%
1 Year Est. Return
-13.74%
3 Year Est. Return
+21.12%
5 Year Est. Return
+59.28%
10 Year Est. Return
–
AUM
$277M
AUM Growth
+$53.4M
(+24%)
Cap. Flow
+$91.9M
Cap. Flow
% of AUM
33.24%
Top 10 Holdings %
Top 10 Hldgs %
42.43%
Holding
129
New
15
Increased
21
Reduced
20
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackRock Health Sciences Trust
BME
|
+$26.4M |
| 2 |
WPG
Washington Prime Group Inc.
WPG
|
+$15.1M |
| 3 |
Schwab U.S Small- Cap ETF
SCHA
|
+$14M |
| 4 |
Archer Daniels Midland
ADM
|
+$11.5M |
| 5 |
Schwab US Broad Market ETF
SCHB
|
+$8.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB InBev
BUD
|
+$6.66M |
| 2 |
Idexx Laboratories
IDXX
|
+$1.19M |
| 3 |
JPMorgan Chase
JPM
|
+$802K |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$698K |
| 5 |
Acuity Brands
AYI
|
+$631K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.18% |
| 2 | Industrials | 9.74% |
| 3 | Technology | 9.63% |
| 4 | Healthcare | 6.07% |
| 5 | Communication Services | 5.31% |
Similar funds
TPMI
ARI
TSPM
GHIP
SIO
GPC
TPI
CCONH
Truvvo Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Truvvo Partners held 129 positions worth $277M, up 24% from $223M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Truvvo Partners deployed $91.9M of net new capital in Q2 2017, opening 15 new positions and adding to 21 existing holdings. Its largest new stake was BlackRock Health Sciences Trust: 752,411 shares worth $3.33M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 44% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Idexx Laboratories, an estimated $1.19M trimmed.
- Truvvo Partners's largest Q2 2017 buy was BlackRock Health Sciences Trust: 752,411 shares worth $3.33M.
- Truvvo Partners added most to Wells Fargo in Q2 2017, an estimated $1.27M increase.
- Truvvo Partners's biggest Q2 2017 reduction was Idexx Laboratories, cutting an estimated $1.19M.
- Truvvo Partners fully exited AB InBev in Q2 2017, selling an estimated $6.66M.
- Truvvo Partners's ten largest holdings make up 42% of its $277M portfolio in Q2 2017.
- Truvvo Partners opened 15 new positions and closed 3 in Q2 2017.
- Truvvo Partners's portfolio value rose 24% quarter-over-quarter to $277M.
Based on Truvvo Partners's 13F filing for Q2 2017, filed 27 Jul 2017.